Delivery Order SPE2DB20D3101-SPE2DB22FJ0M8
- Not listed
- This federal contract award, with ID SPE2DX15D6028|SPE2DX25FWENB, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,793.50 firm fixed-price delivery order is for the supply of 4,566,241,965 units of rabies vaccine. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is not designated as a set-aside contract....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,065.36, is for the delivery of rabies vaccine. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 18, 2023. This contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of IMOVAX Rabies Vaccine Vials. The $7,587.59 firm-fixed price delivery order has a completion date of March 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rabies Vaccine 2.5 1S. The contract has a ceiling value of $1,737.27 and is a Firm Fixed Price Delivery Order, with a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31,...
- This is a $42,818.03 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of rabies vaccine. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,947,498 units of Rabies Vaccine 2.5 1S. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $7,073.72 and a period of performance ending on April 18, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,866.53 firm fixed-price delivery order is for the supply of 4,564,722,910 units of Rabies Vaccine 2.5U 1S. The order has a completion date of May 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $15,442.40 to provide rabies vaccine. This award falls under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,203.32 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a critical medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued up to $999,999,999.00 through November 2026. This IDC...
- This is a $2,195.06 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,567,878,915 units of rabies vaccine. The order has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ0M8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4556511778 units of the rabies vaccine IMOGAM RABIES-HT 150 UNIT/ML 2ML. The $7,367.12 Firm Fixed Price delivery order has a performance period ending on March 10, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc., through its Amerisourcebergen Drug Corp subsidiary, to provide a comprehensive range of pharmaceutical products and medical supplies to support the healthcare needs of the Department of Defense and other federal agencies. Additionally, Cencora, Inc. holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 3/9/22 |